|1.||Jiang, Wang-Lin: 2 articles (02/2011 - 05/2009)|
|2.||Zhang, Shu-Min: 1 article (02/2011)|
|3.||Liu, Hong-Zhan: 1 article (02/2011)|
|4.||Tang, Xue-Xi: 1 article (02/2011)|
|5.||Li, Guang Zhao: 1 article (01/2011)|
|6.||Choi, Yun Ho: 1 article (01/2011)|
|7.||Yan, Guang Hai: 1 article (01/2011)|
|8.||Jin, Guang Yu: 1 article (01/2011)|
|9.||Zhu, Hai-Bo: 1 article (05/2009)|
|10.||Tian, Jing-Wei: 1 article (05/2009)|
05/01/2009 - "This work provides first evidence for the clinic use of cornuside as a new immunomodulatory drug that has the capacity to inhibit the inflammatory response in sepsis."
05/01/2009 - "Effect of cornuside on experimental sepsis."
05/01/2009 - "This study was conducted to investigate the efficacy of cornuside, a secoiridoid glucoside compound, in cultured macrophages as well as in an experimental model of sepsis induced by cecal ligation and puncture (CLP) in rats. "
02/15/2011 - "Rat models of myocardial I/R were induced by coronary occlusion followed by reperfusion or by Isoproterenol (ISO), treatment of rats with cornuside (20 and 40 mg/kg, i.v.) protected the animals from myocardial I/R injury as indicated by a decrease in infarct volume, improvement in hemodynamics and reduction of myocardial damage severity. "
|3.||Myocardial Ischemia (Ischemic Heart Diseases)